PrEP Works, But Only When You [Have Access to] Take it: Improving PrEP Access for Young People in Chicago and Philadelphia
Journal Title: International Journal of Virology and AIDS - Year 2016, Vol 3, Issue 1
Abstract
The 2012 United States Food and Drug Administration approval of Tenofovir/Emtricitabine for HIV pre-exposure prophylaxis (PrEP) has added a highly effective, safe biomedical option to the HIV prevention toolbox. In the United States, young black and Latino men who have sex with men (MSM) and transgender women are disproportionately affected by HIV risk over the course of their lifetime.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP353872
- DOI 10.23937/2469-567X/1510020
- Views 142
- Downloads 0
Nucleoside Reverse Transcriptase Inhibitor (NRTI) Associated Macrocytosis
Macrocytosis has been associated with several disease states, vitamin deficiencies, and medications, with nucleoside reverse transcriptase inhibitors (NRTIs) being a less commonly identified cause. NRTIs are frequently u...
The Monitoring of Lymphocyte Populations may be Optional in Patients with Suppressed Viremia: A Two Years Observational Study
The determination of lymphocyte populations (LPs) traditionally has been included in the routine follow-up of HIV-infected patients as an indicator of the degree of immune suppression and of the need to start treatment,...
Sensitive, Subtype Independent HIV-1 PCR Assays for Assessment of Residual Viremia and Total HIV-1 DNA
Background Correct measurements of residual viremia and reservoir size are crucial in HIV-1 eradication trials and there is a need for sensitive and automated assays. The increasing worldwide diversity of HIV-1 subtypes...
Comprehensive Programme to Prevent Cervical Cancer-the Case of Hungary
The overall purpose of a comprehensive cervical cancer prevention programme is to coordinate HPV vaccination (primary prevention) and cervical screening (secondary prevention). Harmonization of the HPV vaccination and po...
Virologic Response and Survival Analysis of 281 HbsAg Treatment Naive Patients on Lamivudine Monotherapy in Sierra Leone
More than 350 million people are infected with Hepatitis B Virus (HBV) globally. The main aim of any chronic hepatitis B therapy is to prevent liver cirrhosis and its sequelae, including Hepatocellular Carcinoma (HCC). T...